✦ LIBER ✦

Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation

✍ Scribed by F. Ferrara; L. Melillo; M. Montillo; F. Leoni; A. Pinto; G. Mele; S. Mirto

Publisher: Springer
Year: 1999
Tongue: English
Weight: 64 KB
Volume: 78
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050533

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine, cytarabine, and G-CSF (FLAG

Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia

✍ Montillo, Marco; Mirto, Salvatore; Petti, Maria Concetta; Latagliata, Roberto; M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG). Median age was 41 (range 11-70). Sixteen patients had AML that was primary resistant to induction treatment, while 22 wer

Letter to the Editor:FLAG (fludarabine,

Letter to the Editor:FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children

✍ Sarper, Nazan; Yalman, Nevin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

## FLAG (Fludarabine, High-Dose Cytarabine and G-CSF) for Refractory and High-Risk Relapsed Acute Leukemia in Children We have read with interest the report about FLAG therapy in childhood acute leukemia by McCarthy et al. [1]. We want to add our experience with IDA-FLAG in poor-risk childhood leuk

Isolated extramedullary relapse after au

Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature

✍ Leonardo Potenza; Mario Luppi; Giovanni Riva; Monica Morselli; Angela Ferrari; A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 3 views

Nilotinib and donor lymphocyte infusion

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib

✍ Mario Tiribelli; Alessandra Sperotto; Anna Candoni; Erica Simeone; Silvia Buttig 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Potential of dendritic cell immunotherap

Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia

✍ Toshio Kitawaki; Norimitsu Kadowaki; Tadakazu Kondo; Takayuki Ishikawa; Tatsuo I 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Successful allogeneic stem-cell transpla

Successful allogeneic stem-cell transplantation with prophylactic stepwise G-CSF primed-DLIs for relapse after autologous transplantation in mantle cell lymphoma: A case report and literature review on the evidence of GVL effects in MCL

✍ S.K. Sohn; J.H. Baek; D.H. Kim; J.T. Jung; D.S. Kwak; S.H. Park; J.S. Suh; K.B. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 3 views